ArticleFrontiers in pharmacology2022

Multicenter, randomized controlled trial of traditional Japanese medicine, kakkonto with shosaikotokakikyosekko, for mild and moderate coronavirus disease patients.

Shin Takayama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.